Business Wire

International Well Building Institute™ and Bre Collaborate on Multiple Levels to Advance Human Health Through Better Buildings

Jaa

In an environment where “partnership is the new leadership,” the International WELL Building Institute™ (IWBI™) and BRE used the recent Greenbuild in Boston Nov. 8-10 to demonstrate to the market the value of collaboration.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171114006416/en/

“Our relationship with BRE is in evidence across several categories,” said IWBI Chairman and CEO Rick Fedrizzi. “We’re proud of the pioneering work we’ve done by developing a crosswalk between the WELL Building Standard™ (WELL™) and BREEAM, simplifying for the market opportunities to use these two leading building standards in tandem to achieve both sustainability and human health goals.

“Additionally, we’ve partnered with BRE to undertake practical performance verification research as we are developing WELL v2,” said Fedrizzi. “Onsite performance verification is a unique hallmark of WELL. When it comes to human health, good intentions and checklists are simply not enough to ensure that a building’s performance is in a position to improve human performance. Our shared commitment to this idea of verified performance is why leadership companies are committing to the high bar that WELL provides.”

A key resource used by BRE in undertaking this performance verification research is the room-sized environmental chamber in which known concentrations of volatile organic compounds (VOCs) or other indoor air pollutants may be introduced into the space at controlled temperature, humidity and ventilation rates. The chamber, built to the “standard room” specifications prescribed in the European Standard CEN/TS 16516: 2013, was designed, built, and commissioned as part of a recent collaborative European Commission (EC) research project.

Two VOC source chambers are used - one to trial the VOC sources and one through which air is passed to carry the VOCs into the chamber. In the current, research the chamber is used to compare VOC measurement methods and technologies for the determination of 'TVOC' (total VOC) in air at given concentrations of selected VOCs.

The current research initiatives being undertaken jointly by BRE and IWBI also involve evaluation of monitors used to measure particulate matter in air, and evaluation of the methods used to measure light levels and to use the data in order to assess circadian lighting.

“We see the value of successive rounds of collaborative research in pushing the envelope when it comes to ensuring that performance verification methodologies are robust and fit for purpose,” said Dr. Andy Dengel, CChem MRSC, Director, BRE Environment. “That’s why we’re excited to showcase this work to WELL practitioners and power users who are contributing to the development of WELL v2.”

“We had tremendous response to BRE’s presentation at the first of our v2 Roundtables, which was held at Greenbuild last week,” said IWBI Chief Product Officer Rachel Gutter. “BRE is a great partner for this work, and we look forward to sharing their methodologies at other v2 Roundtables in the coming months.”

“If we are to drive change for the built environment at all the different scales of design and operation, we need to create strong partnerships with like-minded organizations. In doing so, we can create a supportive environment for the industry to improve the way in which we look at buildings. Such certainty comes from the industry having confidence in an independent approach and standards built on research and science, a belief IWBI and BRE share,” said Martin Townsend, Director of Sustainability at BRE.

About BRE

BRE has been raising the standards of the built environment since 1921, and in the last few years has grown significantly, both through the achievements of our people and the acquisition of businesses with beliefs and goals aligned with our own. Our multi-disciplinary teams include leading experts – working in world-class facilities – in virtually every element of the built environment. They operate internationally, with offices, representatives and partners around the globe, and at our Head Office and major facilities in the UK. Our long heritage of putting progressive thinking into practice means that our customers and partners, wherever they are in the world, trust us to deliver. BRE is part of the BRE Trust, which uses the profits we make from our services to fund new research and education programmes.

About the International WELL Building Institute™

The International WELL Building Institute (IWBI) is a public benefit corporation that is leading the movement to promote health and wellness in buildings and communities everywhere. IWBI delivers the cutting-edge WELL Building Standard™ and the WELL Community Standard™, performance-based systems for measuring, certifying and monitoring features of buildings and communities that impact the health and wellness of the people who live, work, and learn in them. It also supports the growing number of professionals who seek WELL accreditation, as third-party administered by GBCI. www.wellcertified.com

Contact information

Press:
IWBI
Callie Stanton, 646-654-3438
cstanton@nikecomm.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Manchester United and True Religion Launch Denim Range19.10.2018 20:37Tiedote

Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion

Arch Insurance Announces Strategic Leadership Changes19.10.2018 16:10Tiedote

Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 15:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an

Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 14:54Tiedote

Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr

Tradeshift Announces Q3 2018 Results19.10.2018 14:00Tiedote

Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between

Schlumberger Announces Third-Quarter 2018 Results19.10.2018 14:00Tiedote

Schlumberger Limited (NYSE: SLB) today reported results for the third quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Sept. 30, 2018 Jun. 30, 2018 Sept. 30, 2017 Sequential Year-on-year Revenue $8,504 $8,303 $7,905 2% 8% Pretax operating income $1,152 $1,094 $1,059 5% 9% Pretax operating margin 13.5% 13.2% 13.4% 36 bps 15 bps Net income - GAAP basis $644 $430 $545 50% 18% Net income, excluding charges & credits* $644 $594 $581 8% 11% Diluted EPS - GAAP basis $0.46 $0.31 $0.39 48% 18% Diluted EPS, excluding charges & credits* $0.46 $0.43 $0.42 7% 10% North America revenue $3,189 $3,139 $2,602 2% 23% International revenue $5,215 $5,065 $5,147 3% 1% North America revenue, excluding Cameron $2,572 $2,546 $2,086 1% 23% International revenue, excluding Cameron $4,559 $4,387 $4,430 4% 3% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commented, “Our third

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme